Report a data issue, formatting problem, or request follow-up. Our team responds within one business day.
Be the first to review this report.
Collagen widely exists in all multicellular animals. It is the most abundant protein in the body, accounting for about a quarter of the total protein in the human body. It is an extracellular protein in almost all tissues. It exists in the form of insoluble fibers and has high tensile capacity. It has great influence on the formation of skin, blood vessels, bones, tendons and cartilage in animals and human bodies It is an important material of connective tissue and a major factor determining the toughness of connective tissue. It plays a role of binding tissue in animal cells. Colloquially, collagen is only a part of collagen. Because the molecular weight of collagen ranges from 500 to 30000, the human body can directly absorb it. If it is too small, it is oligopeptide or polypeptide, which is no big difference from amino acid for human body. The larger molecular weight is hundreds of thousands to millions of macromolecules, which is collagen. Human body can't absorb collagen, which is the root of understanding that "collagen" can't be absorbed.
Global Collagen Peptides key players include Rousselot S.A.S., Gelita, PB Leiner, etc. Global top three manufacturers hold a share about 35%.
Europe is the largest market, with a share about 30%, followed by China, and North America, both have a share about 45 percent.
In terms of product, Porcine collagen is the largest segment, with a share about 35%. And in terms of application, the largest application is Food Industrial, followed by Health Products Industrial, Cosmetics Industrial, etc.
This report quantifies the global Collagen Peptides market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Collagen Peptides.
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Collagen Peptides manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Collagen Peptides by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Collagen Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
You may also be interested in
